Biomarkers to Guide MBC Treatment Decisions: dMMR/MSI-H, TMB, and NTRK Fusion
In part 2 of a 3-part series, read about the new recommendations and the dMMR/MSI-H, TMB, and NTRK fusion biomarkers.
Read More
The Latest Research on CDK 4/6 Inhibitors
Learn about new CDK 4/6 inhibitor research in different breast cancer subtypes, including HER2+ and triple-negative MBC.
Patient-Reported Outcomes: Including the Patient Voice in MBC Research
Patient-reported outcomes are essential to understand and improve the quality of life of people with MBC. Read more here.
Participate in SABCS 2022
The San Antonio Breast Cancer Symposium is December 6-10. Learn how to participate and hear about the latest research findings.
New Clinical Trials For Stage IV Breast Cancer
New clinical trials for stage 4 breast cancer are available. See clinical trials for HR-positive, HER2-positive, triple-negative, and other subtypes.
Why You Should Consider Repeat Biopsies
Learn about the importance of repeat biopsies and how they affect treatment decisions and clinical trial eligibility.
New To Clinical Trials?
The idea of finding and entering a clinical trial can seem daunting. Here’s a Clinical Trials Primer to get you started.
SEARCH OUR SITE
for past articles or specific information.